Ebook: The enzyme treatment of cancer and its scientific basis : being collected papers dealing with the origin, nature, and scientific treatment of the natural phenomenon known as malignant disease

This is the complete, assembled pdf of the book posted on the vitamin c foundation website. Pictures are included. In a 1902 article written for the British medical journal Lancet, the English scientist John Beard, at the time Professor at the University of Edinburgh, first proposed that the pancreatic enzyme trypsin represents the body’s primary defense against cancer and would be useful as a cancer treatment. Beard came to his conclusion as the result of some 20 years of hard laboratory research, that today holds up to rigorous scientific scrutiny. Despite his documentation and his impeccable reputation—he would be nominated for the Nobel Prize in 1905 for his work in embryology—the vast majority of cancer experts categorically rejected Beard’s thesis outright. But not everyone dismissed Dr. Beard. A number of physicians concluded that Beard might be right, and with his support began employing injectable pancreatic enzymes in the treatment of their own patients diagnosed with advanced cancer, often with remarkable results as reported in the conventional scientific literature. These successes seemed to provoke an even more intense backlash against the treatment, in a heated debate that lasted right through the first decade of the 20th century. In response to his critics, in 1911 Beard published The Enzyme Treatment of Cancer and Its Scientific Basis, outlining his hypothesis, his decades of research and the promising and compelling results. Though released by a major London publisher to some very positive reviews, the book was soon forgotten as the scientific community and the media enthusiastically latched on to Madame Curie’s claim that radiation represented a simple, easy, non-toxic cure for cancer. It would be years before scientists realized radiation cured few cancers and was quite toxic—Madame Curie herself died as a result of her exposure to uranium—but by that time, Beard was dead and forgotten. John Beard was a brilliant biologist whose main research interest was pregnancy and the placenta, in particular. He made or confirmed several crucial observations that led to his theory of cancer. He observed under the microscope that the trophoblast cells that form the placenta looked like cancer cells. Beard then made an extraordinary observation: The placenta stops growing on day 56 of the human pregnancy - on the same day the fetus's pancreas begins to function. He came to the conclusion that the fetus's pancreas secreted something that stopped the growth of the placenta. He then surmised, and later proved, that the same substance stopped the growth of malignant cancer. He set out to determine what this pancreatic substance was. Beard conducted experiments with the juices extracted from young animal pancreases. These juices were injected into cancer tumors and the tumors shrank in both animals and humans. Beard's work was published in JAMA and he wrote a book on the enzyme therapy for cancer. One hundred years ago, physicians tried to duplicate Beard's experimental results, but they failed, and the work was almost forgotten. We now know that delicate enzymes can lose their effectiveness if not carefully extracted from young live stock. Even though trypsin was one of the first proteins whose molecular structure was deciphered by chemists in the 1960s, we are still not able to synthesize either trypsin or chymotrypsin. As pure trypsin must be extracted intact from young livestock, the cost of supplements with these enzymes is high. The cost at the dosage recommended by enzyme/cancer experts may exceed $2000 per month. We all begin our lives as a single undifferentiated cell. This cell called a zygote, a sort of "super" stem cell, divides into trillions of progeny. Living cells change after succeeding divisions in the process of differentiation, but not all cells become muscle, bone, eyes, teeth, hair, connective or other tissue. Some cells form into the placenta, a trophoblastic layer of tissue that attaches to the uterine wall during pregnancy. The placenta is discarded by the mother's body after birth. Beard, the first to observe that placenta cells resemble cancer cells, also saw how malignant cancers act in the same way that placenta cells do in the mother's womb; -- they attach to the uterus and eat through it to obtain a blood supply. Beard also found other out-of-place trophoblast cells in great numbers throughout the body. These cells are placenta-like, do not differentiate into specific tissue, but lie dormant. Beard called these cells 'germ' cells. They have properties similar to stem cells, and Beard believed that these cells are the seeds of cancer. He theorized that, as we age, the germ cells are likely to receive a signal that causes them to begin growing. The conditions that induce growth might include a hormonal message that the germ cells interpret as a pregnancy. The estrogen-based hormonal signal that mimics pregnancy may be induced by physical trauma, or by other unknown reasons. As this false-placenta begins growing, unchecked, it becomes the malignant mass which the medical community calls cancer. The pancreas produces the protein dissolving enzymes trypsin (and its precursor chymotrypsin) that Beard believed prevents germ cells from becoming malignant. The pancreas secretes digestive enzymes into the small intestine where they help digest cooked or denatured proteins. Some of these enzymes enter the blood stream. In theory, when the pancreas is healthy, early-stage cancers (false pregnancies) are destroyed (digested) by pancreatic enzymes in the blood. Cancer is best understood as pancreas failure to produce trypsin, in the same way that Diabetes (Type I) is a failure of the pancreas to produce insulin. Beard believed that when the health of the pancreas becomes impaired and the output of pancreatic enzymes declines or stops, any malignant cancer cell that begins dividing grows out of control. In Beard's time it was believed that enzymes taken orally would not enter the blood stream. Even today there is controversy as to whether or not the large enzyme molecules can be absorbed, and whether the enzyme molecule remains intact in the stomach. The reported success rates of Beard's followers tells us that the trypsin enzymes may be taken by mouth, but, very large amounts are required to make them effective against growing cancers. Note: Cancer patients may not be breaking down oral trypsin. If the cancer patients pancreas is malfunctioning, it is not producing the protein digesting enzyme trypsin, then the body would not readily digest proteins (e.g. enzymes) taken by mouth. An interesting discovery is that trypsin's digestive enzyme action on protein is activated by the high pH (8.0 highly alkaline) environment in the small intestine. Cancer of the small intestine is rare. This may help explain the effectiveness of the increasingly popular cesium treatment for cancer. The Cesium treatment raises the pH of the cancer to 8.0 and this may be able to "amplify" the digestive effect of any trypsin present in the blood stream. Max Wolf In the 1940s, researchers discovered that there was something in the blood of people without cancer that was completely missing in the blood of people who had cancer. This clue prompted Dr. Max Wolf to read John Beard's book. Than, Dr. Wolf along with his associate Helen Benitez and Dr. Karl Ransberger, a young biomedical researcher from Germany, tested numerous enzymes from animal and plant sources, and created an enzyme formula containing both trypsin and chymotrypsin. Today, the Wolf/Benitez WoBenzyme® systemic enzyme formula is reportedly the second hottest selling OTC product in parts of Europe - behind ordinary aspirin.

---

This is the complete, assembled pdf of the book posted on the vitamin c foundation. In a 1902 article written for the British medical journal Lancet, the English scientist John Beard, at the time Professor at the University of Edinburgh, first proposed that the pancreatic enzyme trypsin represents the body’s primary defense against cancer and would be useful as a cancer treatment. Beard came to his conclusion as the result of some 20 years of hard laboratory research, that today holds up to rigorous scientific scrutiny. Despite his documentation and his impeccable reputation—he would be nominated for the Nobel Prize in 1905 for his work in embryology—the vast majority of cancer experts categorically rejected Beard’s thesis outright. But not everyone dismissed Dr. Beard. A number of physicians concluded that Beard might be right, and with his support began employing injectable pancreatic enzymes in the treatment of their own patients diagnosed with advanced cancer, often with remarkable results as reported in the conventional scientific literature. These successes seemed to provoke an even more intense backlash against the treatment, in a heated debate that lasted right through the first decade of the 20th century. In response to his critics, in 1911 Beard published The Enzyme Treatment of Cancer and Its Scientific Basis, outlining his hypothesis, his decades of research and the promising and compelling results. Though released by a major London publisher to some very positive reviews, the book was soon forgotten as the scientific community and the media enthusiastically latched on to Madame Curie’s claim that radiation represented a simple, easy, non-toxic cure for cancer. It would be years before scientists realized radiation cured few cancers and was quite toxic—Madame Curie herself died as a result of her exposure to uranium—but by that time, Beard was dead and forgotten. John Beard was a brilliant biologist whose main research interest was pregnancy and the placenta, in particular. He made or confirmed several crucial observations that led to his theory of cancer. He observed under the microscope that the trophoblast cells that form the placenta looked like cancer cells. Beard then made an extraordinary observation: The placenta stops growing on day 56 of the human pregnancy - on the same day the fetus's pancreas begins to function. He came to the conclusion that the fetus's pancreas secreted something that stopped the growth of the placenta. He then surmised, and later proved, that the same substance stopped the growth of malignant cancer. He set out to determine what this pancreatic substance was. Beard conducted experiments with the juices extracted from young animal pancreases. These juices were injected into cancer tumors and the tumors shrank in both animals and humans. Beard's work was published in JAMA and he wrote a book on the enzyme therapy for cancer. One hundred years ago, physicians tried to duplicate Beard's experimental results, but they failed, and the work was almost forgotten. We now know that delicate enzymes can lose their effectiveness if not carefully extracted from young live stock. Even though trypsin was one of the first proteins whose molecular structure was deciphered by chemists in the 1960s, we are still not able to synthesize either trypsin or chymotrypsin. As pure trypsin must be extracted intact from young livestock, the cost of supplements with these enzymes is high. The cost at the dosage recommended by enzyme/cancer experts may exceed $2000 per month. We all begin our lives as a single undifferentiated cell. This cell called a zygote, a sort of "super" stem cell, divides into trillions of progeny. Living cells change after succeeding divisions in the process of differentiation, but not all cells become muscle, bone, eyes, teeth, hair, connective or other tissue. Some cells form into the placenta, a trophoblastic layer of tissue that attaches to the uterine wall during pregnancy. The placenta is discarded by the mother's body after birth. Beard, the first to observe that placenta cells resemble cancer cells, also saw how malignant cancers act in the same way that placenta cells do in the mother's womb; -- they attach to the uterus and eat through it to obtain a blood supply. Beard also found other out-of-place trophoblast cells in great numbers throughout the body. These cells are placenta-like, do not differentiate into specific tissue, but lie dormant. Beard called these cells 'germ' cells. They have properties similar to stem cells, and Beard believed that these cells are the seeds of cancer. He theorized that, as we age, the germ cells are likely to receive a signal that causes them to begin growing. The conditions that induce growth might include a hormonal message that the germ cells interpret as a pregnancy. The estrogen-based hormonal signal that mimics pregnancy may be induced by physical trauma, or by other unknown reasons. As this false-placenta begins growing, unchecked, it becomes the malignant mass which the medical community calls cancer. The pancreas produces the protein dissolving enzymes trypsin (and its precursor chymotrypsin) that Beard believed prevents germ cells from becoming malignant. The pancreas secretes digestive enzymes into the small intestine where they help digest cooked or denatured proteins. Some of these enzymes enter the blood stream. In theory, when the pancreas is healthy, early-stage cancers (false pregnancies) are destroyed (digested) by pancreatic enzymes in the blood. Cancer is best understood as pancreas failure to produce trypsin, in the same way that Diabetes (Type I) is a failure of the pancreas to produce insulin. Beard believed that when the health of the pancreas becomes impaired and the output of pancreatic enzymes declines or stops, any malignant cancer cell that begins dividing grows out of control. In Beard's time it was believed that enzymes taken orally would not enter the blood stream. Even today there is controversy as to whether or not the large enzyme molecules can be absorbed, and whether the enzyme molecule remains intact in the stomach. The reported success rates of Beard's followers tells us that the trypsin enzymes may be taken by mouth, but, very large amounts are required to make them effective against growing cancers. Note: Cancer patients may not be breaking down oral trypsin. If the cancer patients pancreas is malfunctioning, it is not producing the protein digesting enzyme trypsin, then the body would not readily digest proteins (e.g. enzymes) taken by mouth. An interesting discovery is that trypsin's digestive enzyme action on protein is activated by the high pH (8.0 highly alkaline) environment in the small intestine. Cancer of the small intestine is rare. This may help explain the effectiveness of the increasingly popular cesium treatment for cancer. The Cesium treatment raises the pH of the cancer to 8.0 and this may be able to "amplify" the digestive effect of any trypsin present in the blood stream. Max Wolf In the 1940s, researchers discovered that there was something in the blood of people without cancer that was completely missing in the blood of people who had cancer. This clue prompted Dr. Max Wolf to read John Beard's book. Than, Dr. Wolf along with his associate Helen Benitez and Dr. Karl Ransberger, a young biomedical researcher from Germany, tested numerous enzymes from animal and plant sources, and created an enzyme formula containing both trypsin and chymotrypsin. Today, the Wolf/Benitez WoBenzyme® systemic enzyme formula is reportedly the second hottest selling OTC product in parts of Europe - behind ordinary aspirin.